Publication | Open Access
Liver <scp>GPBAR1</scp> Associates With Immune Dysfunction in Primary Sclerosing Cholangitis and Its Activation Attenuates Cholestasis in Abcb4−/− Mice
10
Citations
34
References
2025
Year
Our study provides evidence for the therapeutic potential of selective GPBAR1 agonists in intestinal inflammation-associated cholestasis, warranting the evaluation of BAR501 in PSC patients.
| Year | Citations | |
|---|---|---|
Page 1
Page 1